When Georges Favre-Jacot started his watchmaking company in 1865, he was already convinced that emotion arises from a combination of daring and authenticity. Later, to suggest that his brand offered the ultimate in expertise and high standards, he renamed the company after the highest point in the sky: Zenith.
As an integral part of a brand’s heritage, values enable the brand to construct a “moral framework,” a guideline that underlies all of its external and internal discourse. Zenith’s values have always clearly shown through in its decisions, actions, and collections.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60648-zenith-watchmaking-daring-vistas
The most stressful week of the year is upon us; the last week of holiday shopping. As consumers across the country seek those last minute gifts, their stress levels rise. Zazen Bear, the retailer whose concept is about connection, harmony and peace, is offering consumers gifts that inspire finding those moments of peace in your day.
To celebrate this season, Zazen Bear has released a video series, titled “Zen Tree,” to showcase their jewelry collections while giving the viewer a sense of relaxation and peace. Every Holiday Season, consumers decorate trees to reflect the festive spirit; whether it is with ornaments, lights, garland, or a combination of all, each tree has its own specific design. Zazen Bear took this holiday staple, visualizing it with a peaceful and minimal aesthetic. The “Zen Tree” series celebrates the Holiday Season by presenting the Zazen Bear jewelry collections as ornaments decorating a forest of Christmas trees.
To view the multimedia release go to:
http://www.multivu.com/players/English/7656031-zazen-bear/
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
A phase 1 clinical trial of the drug crizotinib achieved remissions, with minimal side effects, for 10 of the children participating in a clinical study carried out by the multicenter Children’s Oncology Group (COG). The results were “an exciting proof-of-principle” for the targeted treatment, said the study leader, Yaël P. Mossé, M.D., a pediatric oncologist at The Children’s Hospital of Philadelphia.
“We are entering a new era of cancer therapy, in which we use knowledge of basic biology to design very specific drugs that target cancer cells with potentially less side effects on healthy tissue,” said Mossé. “In addition, as we concentrate on targets in molecular pathways, we move away from an exclusive focus on one form of cancer to customizing treatments according to biological activity. Abnormal ALK activity occurs in subtypes of neuroblastoma and subtypes of lymphoma, so identifying ALK activity in individual patients may enable us to provide the most effective care.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial
zNitro (znitro.com), a Clear Protector company, today announced it will launch its exclusive lineup of Nitro electronics accessories at the Macworld/iWorld Show 2013. zNitro will be located at Booth 809 in the Moscone Center of this gala San Francisco event scheduled for January 31- February 2, 2013.
Building on the exceptional reputation for quality established by its Clear Protector predecessor, zNitro will continue to offer outstanding value and top-of-the-line products for consumers.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59895-former-clear-protector-znitro-mobile-electronic-devices-accessories
